166
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Preliminary studies on the selective accumulation of vitamin-targeted polymers within tumors

, &
Pages 133-139 | Received 06 Nov 2009, Accepted 19 Feb 2010, Published online: 06 May 2010

References

  • Axworthy DB, Reno JM, Hylarides MD, Mallett RW, Theodore LJ, Gustavson LM, Su F, Hobson LJ, Beaumier PL, Fritzberg AR. (2000). Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity. Proc Natl Acad Sci USA, 97, 1802–1807.
  • Baur B, Baumgartner ER. (2000). Biotin and biocytin uptake into cultured primary calf brain microvessel endothelial cells of the blood-brain barrier. Brain Res, 858, 348–355.
  • Birn H, Willnow TE, Nielsen R, Norden AG, Bönsch C, Moestrup SK, Nexø E, Christensen EI. (2002). Megalin is essential for renal proximal tubule reabsorption and accumulation of transcobalamin-B(12). Am J Physiol Renal Physiol, 282, F408–F416.
  • Blomquist L, Flodh H, Ullberg S. (1969). Uptake of labeled vitamin B12 and 4-Iodophenylalanine in some tumours of mice. Specialia, 15, 294–296.
  • Boerman OC, van Niekerk CC, Makkink K, Hanselaar TG, Kenemans P, Poels LG. (1991). Comparative immunohistochemical study of four monoclonal antibodies directed against ovarian carcinoma-associated antigens. Int J Gynecol Pathol, 10, 15–25.
  • Boerman OC, van Schaijk FG, Oyen WJ, Corstens FH. (2003). Pretargeted radioimmunotherapy of cancer: progress step by step. J Nucl Med, 44, 400–411.
  • Breitz HB, Weiden PL, Beaumier PL, Axworthy DB, Seiler C, Su FM, Graves S, Bryan K, Reno JM. (2000). Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin. J Nucl Med, 41, 131–140.
  • Carmel R, Hollander D. (1978). Extreme elevation of transcobalamin II levels in multiple myeloma and other disorders. Blood, 51, 1057–1063.
  • Casalini P, Luison E, Ménard S, Colnaghi MI, Paganelli G, Canevari S. (1997). Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization. J Nucl Med, 38, 1378–1381.
  • Chalifour LE, Dakshinamurti K. (1983). The partial characterization of the binding of avidin-biotin complex to rat liver plasma membrane. Biochem J, 210, 121–128.
  • Chauhan J, Dakshinamurti K. (1988). Role of human serum biotinidase as biotin-binding protein. Biochem J, 256, 265–270.
  • Collins DA, Hogenkamp HP, Gebhard MW. (1999). Tumor imaging via indium 111-labeled DTPA-adenosylcobalamin. Mayo Clin Proc, 74, 687–691.
  • Collins DA, Hogenkamp HP, O’Connor MK, Naylor S, Benson LM, Hardyman TJ, Thorson LM. (2000). Biodistribution of radiolabeled adenosylcobalamin in patients diagnosed with various malignancies. Mayo Clin Proc, 75, 568–580.
  • Coney LR, Tomassetti A, Carayannopoulos L, Frasca V, Kamen BA, Colnaghi MI, Zurawski VRJr, (1991). Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. Cancer Res, 51, 6125–32.
  • Correa-González L, Arteaga de Murphy C, Ferro-Flores G, Pedraza-López M, Murphy-Stack E, Mino-León D, Pérez-Villaseñor G, Díaz-Torres Y, Muñóz-Olvera R. (2003). Uptake of 153Sm-DTPA-bis-biotin and 99mTc-DTPA-bis-biotin in rat as-30D-hepatoma cells. Nucl Med Biol, 30, 135–140.
  • Flodh J. (1968). Accumulation of labeled vitamin B-12 in some transplanted tumors. Acta Radiol. Suppl., 284, 55–60.
  • Flodh J, Ullberg S. (1968). Accumulation of labeled vitamin B12 in some transplanted tumours. Int. J. Cancer, 3, 694–699.
  • Garin-Chesa P, Campbell I, Saigo PE, Lewis JL Jr, Old LJ, Rettig WJ. (1993). Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am J Pathol, 142, 557–567.
  • Gottschalk S, Cristiano RJ, Smith LC, Woo SL. (1994). Folate receptor mediated DNA delivery into tumor cells: potosomal disruption results in enhanced gene expression. Gene Ther, 1, 185–191.
  • Grana C, Chinol M, Robertson C, Mazzetta C, Bartolomei M, De Cicco C, Fiorenza M, Gatti M, Caliceti P, Paganelli G. (2002). Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot study. Br J Cancer, 86, 207–212.
  • Hytönen VP, Määttä JA, Niskanen EA, Huuskonen J, Helttunen KJ, Halling KK, Nordlund HR, Rissanen K, Johnson MS, Salminen TA, Kulomaa MS, Laitinen OH, Airenne TT. (2007). Structure and characterization of a novel chicken biotin-binding protein A (BBP-A). BMC Struct Biol, 7, 8.
  • Jensen HS, Gimsing P, Pedersen F, Hippe E. (1983). Transcobalamin II as an indicator of activity in metastatic renal adenocarcinoma. Cancer, 52, 1700–1704.
  • Lindner J, Geczy AF, Russell-Jones GJ. (1994). Identification of the site of uptake of the E. coli heat-labile enterotoxin, LTB. Scand J Immunol, 40, 564–572.
  • Kane SP, Murray-Lyon IM, Paradinas FJ, Johnson PJ, Williams R, Orr AH, Kohn J. (1978). Vitamin B12 binding protein as a tumour marker for hepatocellular carcinoma. Gut, 19, 1105–1109.
  • Leamon CP, Low PS. (1991). Delivery of macromolecules into living cells: A method that exploits folate receptor endocytosis. PNAS, 88, 5572–5576.
  • Mandella RD, Meslar HW, White HB 3rd. (1978). Relationship between biotin-binding proteins from chicken plasma and egg yolk. Biochem J, 175, 629–633.
  • Murthy CV, Adiga PR. (1984). Purification of biotin-binding protein from chicken egg yolk and comparison with avidin. Biochim Biophys Acta, 786, 222–230.
  • Na K, Bum Lee T, Park KH, Shin EK, Lee YB, Choi HK. (2003). Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system. Eur J Pharm Sci, 18, 165–173.
  • Paganelli G, Magnani P, Zito F, Villa E, Sudati F, Lopalco L, Rossetti C, Malcovati M, Chiolerio F, Seccamani E, Siccardi AG, Fazio F. (1991). Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients. Cancer Res, 51, 5960–5966.
  • Park S, Sinko PJ. (2005). The blood-brain barrier sodium-dependent multivitamin transporter: a molecular functional in vitro-in situ correlation. Drug Metab Dispos, 33, 1547–1554.
  • Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, Leamon CP. (2005). Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem, 338, 284–293.
  • Pispa J. (1965). Animal biotinidase. Ann Med Exp Biol Fenn, 43(Suppl. 5), 1–39.
  • Prasad PD, Wang H, Huang W, Fei YJ, Leibach FH, Devoe LD, Ganapathy V. (1999). Molecular and functional characterization of the intestinal Na+-dependent multivitamin transporter. Arch Biochem Biophys, 366, 95–106.
  • Prasad PD, Wang H, Kekuda R, Fujita T, Fei YJ, Devoe LD, Leibach FH, Ganapathy V. (1998). Cloning and functional expression of a cDNA encoding a mammalian sodium-dependent vitamin transporter mediating the uptake of pantothenate, biotin, and lipoate. J Bio Chem, 273, 7501–7506.
  • Rachmilewitz B, Rachmilewitz M, Moshkowitz B, Gross J. (1971). Serum transcobalamin in myeloid leukemia. J Lab Clin Med, 78, 275–288.
  • Rachmilewitz B, Sulkes A, Rachmilewitz M, Fuks Z. (1981). Serum transcobalamin II levels in breast carcinoma patients. Isr J Med Sci, 17, 874–878.
  • Reddy JA, Dean D, Kennedy MD, Low PS. (1999). Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy. J Pharm Sci, 88, 1112–1118.
  • Reddy JA, Low PS. (1998). Folate-mediated targeting of therapeutic and imaging agents to cancers. Crit Rev Ther Drug Carrier Syst, 15, 587–627.
  • Reddy JA, Low PS. (2000). Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. J Control Release, 64, 27–37.
  • Review Low PS. (1995). Vitamin-mediated delivery of protein, antisense oligonucleotides and genes into living cells. Restorative Neurol. Neurosci., 8, 15.
  • Russell-Jones G, McTavish K, McEwan J, Rice J, Nowotnik D. (2004). Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours. J Inorg Biochem, 98, 1625–1633.
  • Said HM, Redha R, Nylander W. (1987). A carrier-mediated, Na+ gradient-dependent transport for biotin in human intestinal brush-border membrane vesicles. Am J Physiol, 253, G631–G636.
  • Seshagiri PB, Adiga PR. (1987a). Isolation and characterisation of a biotin-binding protein from the pregnant-rat serum and comparison with that from the chicken egg-yolk. Biochim Biophys Acta, 916, 474–481.
  • Seshagiri PB, Adiga PR. (1987b). Identification and molecular characterisation of a biotin-binding protein distinct from avidin of chicken egg white and comparison with yolk biotin-binding protein. Biochim Biophys Acta, 926, 321–330.
  • Stanley JS, Mock DM, Griffin JB, Zempleni J. (2002). Biotin uptake into human peripheral blood mononuclear cells increases early in the cell cycle, increasing carboxylase activities. J Nutr, 132, 1854–1859.
  • Turek JJ, Leamon CP, Low PS. (1993). Endocytosis of folate-protein conjugates: ultrastructural localization in KB cells. J Cell Sci, 106, 423–30.
  • Toffoli G, Cernigoi C, Russo A, Gallo A, Bagnoli M, Boiocchi M. (1997). Overexpression of folate binding protein in ovarian cancers. Int J Cancer, 74, 193–198.
  • Toffoli G, Russo A, Gallo A, Cernigoi C, Miotti S, Sorio R, Tumolo S, Boiocchi M. (1998). Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer. Int J Cancer, 79, 121–126.
  • Wang S, Low PS. (1998). Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. J Control Release, 53, 39–48.
  • Weitman SD, Lark RH, Coney LR, Fort DW, Frasca V, Zurawski VR Jr, Kamen BA. (1992). Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res, 52, 3396–3401.
  • White HB 3rd. (1985). Biotin-binding proteins and biotin transport to oocytes. Ann N Y Acad Sci, 447, 202–211.
  • White HB 3rd, Whitehead CC. (1987). Role of avidin and other biotin-binding proteins in the deposition and distribution of biotin in chicken eggs. Discovery of a new biotin-binding protein. Biochem J, 241, 677–684.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.